Business Description
PDS Biotechnology Corp
NAICS : 325412
SIC : 2834
ISIN : US2798701098
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.37 | |||||
Equity-to-Asset | 0.44 | |||||
Debt-to-Equity | 0.91 | |||||
Debt-to-EBITDA | -0.59 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -13.4 | |||||
3-Year EPS without NRI Growth Rate | -16 | |||||
3-Year FCF Growth Rate | -11.5 | |||||
3-Year Book Growth Rate | -13.5 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 63.62 | |||||
9-Day RSI | 49.35 | |||||
14-Day RSI | 43.11 | |||||
6-1 Month Momentum % | 14.53 | |||||
12-1 Month Momentum % | -21.61 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.33 | |||||
Quick Ratio | 4.33 | |||||
Cash Ratio | 4.15 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -14.1 | |||||
Shareholder Yield % | -23.27 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -127.75 | |||||
ROA % | -65.9 | |||||
ROIC % | -2989.99 | |||||
ROC (Joel Greenblatt) % | -9603.35 | |||||
ROCE % | -71.39 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 4.13 | |||||
Price-to-Tangible-Book | 4.18 | |||||
EV-to-EBIT | -2.16 | |||||
EV-to-Forward-EBIT | -1.71 | |||||
EV-to-EBITDA | -2.16 | |||||
EV-to-Forward-EBITDA | -1.71 | |||||
EV-to-Forward-Revenue | 2.76 | |||||
EV-to-FCF | -2.58 | |||||
Price-to-Net-Current-Asset-Value | 4.24 | |||||
Price-to-Net-Cash | 4.71 | |||||
Earnings Yield (Greenblatt) % | -46.23 | |||||
FCF Yield % | -28.12 |